Mahsa Abassi
University of Minnesota
52 Papers
25 Citations
Mahsa Abassi is an academic researcher from University of Minnesota. The author has contributed to research in topics: Medicine & Meningitis. The author has an hindex of 15, co-authored 36 publications. Previous affiliations of Mahsa Abassi include Makerere University & McGill University.
Chat about Author
Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
David R. Boulware,Matthew F Pullen,Ananta S. Bangdiwala,Katelyn A Pastick,Sarah M Lofgren,Elizabeth C Okafor,Caleb P Skipper,Alanna A Nascene,Melanie R. Nicol,Mahsa Abassi,Nicole W. Engen,Matthew P. Cheng,Derek LaBar,Sylvain A. Lother,Lauren J. MacKenzie,Glen Drobot,Nicole Marten,Ryan Zarychanski,Lauren E. Kelly,Ilan S. Schwartz,Emily G. McDonald,Radha Rajasingham,Todd C. Lee,Kathy H. Hullsiek +23 more
TL;DR: After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid -19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure.
1.3K
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.
Caleb P Skipper,Katelyn A Pastick,Nicole S Engen,Ananta S Bangdiwala,Mahsa Abassi,Sarah M Lofgren,Darlisha A. Williams,Elizabeth C Okafor,Matthew F Pullen,Melanie R. Nicol,Alanna A Nascene,Katherine Huppler Hullsiek,Matthew P. Cheng,Darlette Luke,Sylvain A. Lother,Lauren J. MacKenzie,Glen Drobot,Lauren E. Kelly,Ilan S. Schwartz,Ryan Zarychanski,Emily G. McDonald,Todd C. Lee,Radha Rajasingham,David R. Boulware +23 more
TL;DR: This randomized, double-blind, placebo-controlled trial evaluated effects of oral hydroxychloroquine on symptoms and disease severity in adult outpatients with early COVID-19.
Cryptococcal Meningitis: Diagnosis and Management Update
TL;DR: Targeted screening and treatment programs for cryptococcal antigenemia are a cost-effective method for reducing early mortality on antiretroviral therapy (ART) and optimal initial management with amphotericin and flucytosine improves survival against alternative therapies.
Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda
Mahsa Abassi,Bozena M. Morawski,Gertrude Nakigozi,Noeline Nakasujja,Xiangrong Kong,David B. Meya,David B. Meya,Kevin Robertson,Ronald H. Gray,Maria J. Wawer,Ned Sacktor,David R. Boulware +11 more
TL;DR: Proinflammatory CSF cytokines, chemokines, and neurodegenerative biomarkers were present in increasing concentrations with advanced immunosuppression and may play a role in the development of HAND.
63
Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation
Joshua Rhein,Joshua Rhein,Katherine Huppler Hullsiek,Emily E Evans,Lillian Tugume,Edwin Nuwagira,Kenneth Ssebambulidde,Reuben Kiggundu,Edward Mpoza,Abdu K Musubire,Ananta S Bangdiwala,Nathan C. Bahr,Nathan C. Bahr,Darlisha A. Williams,Darlisha A. Williams,Mahsa Abassi,Mahsa Abassi,Conrad Muzoora,David B. Meya,David B. Meya,David R. Boulware,Astro-Cm study team +21 more
TL;DR: Conclusions Cryptococcosis after ART initiation is common in Africa and patients initiating ART who unmask cryptococcal meningitis are at a high risk of death.